Skip to content

Effects of Stellate Ganglion Block on Postoperative Sleep Disturbance in Elderly Patients after Orthopedic Surgery

Effects of Stellate Ganglion Block on Postoperative Sleep Disturbance in Elderly Patients after Orthopedic Surgery

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400094275
Enrollment
Unknown
Registered
2024-12-19
Start date
2025-01-30
Completion date
Unknown
Last updated
2025-01-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative Sleep Disturbance

Interventions

Stellate ganglion block group:1.Before anesthesia induction, 8ml 0.5% ropivacaine hydrochloride was injected into the right stellate ganglion block under the guidance of ultrasound. The puncture was s
2.Standard clinical anesthesia protocol for completing surgery. 3.Comprehensive postoperative pain management.
Control group:1.Standard clinical anesthesia protocol for completing surgery. 2.Comprehensive postoperative pain management.

Sponsors

Shijingshan Hospital, Beijing, China
Lead Sponsor

Eligibility

Sex/Gender
All
Age
65 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.Age>=65 years; 2.Patients with orthopedic trauma treated with elective surgery; 3.BMI 18~30kg /m^2; 4.Informed consent signed by the patient or legal representative.

Exclusion criteria

Exclusion criteria: 1. Individuals with audiovisual impairments, congnitive impairments, or mental disorders who are unable to complete subsequent assessments; 2. Patients taking sleeping pills; anti-anxiety drugs; anti-depressants for a long period of time; 3. Allergy to test drugs; 4. Preoperative Pittsburgh Sleepiness Quotient Index (PSQI) score greater than 7; 5. History of glaucoma; 6. Infection, scarring, or mass at the site of the stellate nerve block; 7. Limited head and neck movement; 8. Preoperative combination of Honus syndrome or phrenic or recurrent laryngeal nerve palsy; 9. Abnormal cardiac excitation conduction; 10. Myocardial infarction in the last 6 months; 11. History of moderate-to-severe craniocerebral injury or neurosurgery; 12. Abnormal coagulation, bleeding disorders; 13. Severe hepatic insufficiency (Child-Pugh class C); 14. Abnormal renal function (requiring renal replacement therapy).

Design outcomes

Primary

MeasureTime frame
Pittsburgh Sleep Scale (PSQI) score;

Secondary

MeasureTime frame
Numerical Rating Scale;QoR-15 scale;

Countries

China

Contacts

Public ContactPiao Zhe

Shijingshan Hospital, Beijing, China

packzhe@vip.sina.com+86 150 0136 4436

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026